MALDI-TOF study of methylation
MALDI-TOF based experiment was performed according to the protocol developed by Chang etal. 1 MALDI spectrums were collected using Bruker flex control software and analyzed by flex analysis. After labelling each cluster peaks of H3K9Me0, H3K9Me1 and H3K9Me2 for all of the tested concentrations, area under the cluster (AUC) were extracted by using the same flex analysis software. % abundance of each peak was calculated by following formula, A = % Abundance of (H3K9Me0) = area of H3K9Me0/ (area of H3K9Me0+area of H3K9Me1 + area of H3K9Me2) B = % Abundance of (H3K9Me1) = area of H3K9Me1/ (area of H3K9Me0+area of H3K9Me1 + area of H3K9Me2) C = % Abundance of (H3K9Me2) = area of H3K9Me2/ (area of H3K9Me0+area of H3K9Me1 + area of H3K9Me2).
This was repeated for each spectra (3 multiples for each samples).
G9a catalyze dimethylation of H3K9 and hence formation of H3K9Me2 was considered as the product formation and H3K9Me0 and H3K9Me1 is considered substrate not modified to the final product. Hence here % conversion to product is also C, from this to get the %maximal activity (%MA), C was compared to the % conversion when no inhibitor was used (D).
Finally % inhibition was found by subtracting %MA (i) 
Molecular docking study results

HDAC (PDB ID:1T69) protein interactions study
Initially we chose HDAC8 protein structure (PDB ID:1T69) for the docking study because it has SAHA (which we used as the control in cell based assays) as the co-crystallized ligand, but our study revealed a lower GLIDE score and docking score than the expected (Supplementary Table 3) , and so we did a similar study on another HDAC8 protein structure 1T67 and found a higher binding scores and chose this for later study. Gly140, His142, Gly151, Gly206, Phe207, Pro209, Gly304
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Asp101, Tyr306 -+ 
Cytotoxicity study results
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